Notice NOT-HS-23-021 from the NIH Guide for Grants and Contracts

Notice NOT-HS-23-020 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-23-262 from the NIH Guide for Grants and Contracts. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Funding Opportunity PA-23-261 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Negotiable: AstraZeneca : Do you have expertise in, and a passion for leading cross functional teams to generate patient and clinical study data? Would you like to apply your Munich, Germany

Notice NOT-AR-23-023 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-110 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-174 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-051 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-292 from the NIH Guide for Grants and Contracts. Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) intends to support the rigorous assessment of barriers to quality cancer treatment and follow-up care for sexual and gender minority (SGM) cancer survivors. The NCI solicits proposals for observational and/or interventional studies of SGM survivors designed to understand barriers and/or improve care and outcomes for SGM people with cancer, using interoperable sexual orientation and gender identity (SOGI) data collection in cancer care settings.

Funding Opportunity RFA-DK-23-515 from the NIH Guide for Grants and Contracts. The purpose of this limited competition notice of funding opportunity (NOFO) is to continue the support of the Clinical Sites of the NASH Clinical Research Network (NASH CRN) as they complete active clinical treatment trials and continue to longitudinally gather biospecimens and data of children and adults with nonalcoholic fatty liver disease (NAFLD), including steatosis, steatohepatitis, and cirrhosis (NAFLD database study). The NASH CRN has been sponsored by the NIDDK since 2002, and renewed in 2009 and 2014. Research in the NASH CRN has been focused on the etiology, contributing factors, natural history, complications, and therapy of nonalcoholic steatohepatitis.

Competitive Salary: Lonza: United Kingdom, Cambridge United States, Portsmouth (New Hampshire) Today, Lonza is a global leader in life sciences operating across three contine... Cambridge, United Kingdom

Competitive Salary: Lonza: United Kingdom, Cambridge United States, Boston (Massachusetts) Today, Lonza is a global leader in life sciences operating across three continents.... Cambridge, United Kingdom

£40,223 - £44,722 (Grade 4): Barts Cancer Institute , Queen Mary University London: An opportunity to study the drivers of cancer evolution, from its early appearance to response to therapy ( https://www.crick.ac.uk/research/labs/f... London, Greater London, England

The qualified candidate should have received a master's degree in one of the relevant fields, or be currently pursuing the degree with completion before the… $5,000 - $5,554 a month
From Oak Ridge Associated Universities - Wed, 06 Sep 2023 20:13:09 GMT - View all Madison, WI jobs

£33000 - £37000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a LIMS Implementation Officer to join a leading pharmaceutical company expanding on their lab capabilities. The LIMS Implementation Officer will... Hertfordshire

Notice NOT-AI-23-066 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-170 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-173 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-24-035 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to continue critical ongoing network and infrastructure support for advancing development in a specific high-priority area of behavioral and social research on Alzheimers disease (AD) and AD-related dementias (ADRD): The Harmonized Cognitive Assessment Protocol (HCAP) International AD/ADRD Research Network. Network/infrastructure-building activities include but are not limited to meetings to develop novel research areas and interact on the development of infrastructure; small-scale pilots to test or tailor measures in new populations or contexts; development of guidance on selected topics such as biomarkers, diagnosis and classification of dementia, protocol development, fieldwork challenges, statistical harmonization, and analytic methods; educational activities such as intensive summer institutes, series of workshops and related network activities, or advanced seminars on methodology; dissemination and outreach activities; and coordinate activities with other related networks on AD/ADRD.